Protective efficacy of combined monoclonal antibody docaravimab and miromavimab preparation against classical rabies virus: A preclinical study in BALB/c mice

INTRODUCTION. Medicinal products based on monoclonal antibodies (mAbs) is one of the promising options for post-exposure rabies prophylaxis. Since Russian pharmaceutical market does not offer anti-rabies mAbs, a combined docaravimab and miromavimab preparation requires a preclinical study of its pro...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	S. V. Borisevich, V. V. Rubtsov, M. N. Pistsov, S. Ya. Loginova, V. T. Krotkov, R. V. Sakharov, D. A. Kuznetsov, T. E. Sizikova, S. V. Savenko, K. I. Yanovskaya, A. V. Ovchinnikov, A. N. Mironov
Format:	Artigo
Sprache:	Russo
Veröffentlicht:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2025-12-01
Schriftenreihe:	Биопрепараты: Профилактика, диагностика, лечение
Schlagworte:	докаравимаб миромавимаб комбинированный препарат моноклональные антитела бешенство классический вирус бешенства ребинолин мыши balb/с защитная эффективность постэкспозиционная профилактика бешенства
Online-Zugang:	https://www.biopreparations.ru/jour/article/view/675
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!